ARID1A mutation and expression in gynecological cancers
| ARID1A gene mutation | ARID1A loss of expression | |
| Ovarian clear cell carcinoma (%) | 35–75 (52) | 15–75 (45) |
| Ovarian endometroid carcinoma (%) | 30–63 (47) | 31–55 (45) |
| Endometrial clear cell carcinoma (%) | 17 | 20–26 (21) |
| Endometrial endometroid carcinoma (%) | 40–55 (46) | 19–34 (26) |
| Cervical adenocarcinoma (%) | 17 | 9–31 (12) |
| Cervical squamous cell carcinoma (%) | 7 | 7–16 (12) |
| Endometrial carcinosarcoma | 20 | – |
| Ovarian carcinosarcoma | 80 | – |
Values are range (median) or median per cent.